{
  "url": "https://www.law.cornell.edu/regulations/new-york/8-NYCRR-63.9",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 63.9 - Immunizations and emergency treatment of anaphylaxis pursuant to patient specific and non-patient specific orders and protocols",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 63.9 - Immunizations and emergency treatment of anaphylaxis pursuant to patient specific and non-patient specific orders and protocols\n\nState Regulations\n(a) Immunizations. (1)\n\nPursuant to section\n6801\nof the\n\nEducation Law, a pharmacist with a certificate of administration issued by the\ndepartment pursuant to paragraph (3) of this subdivision shall be authorized to\nadminister immunization agents prescribed in paragraph (2) of this subdivision\nto patients therein specified, provided that: (i) the pharmacist meets the requirements for\na certificate of administration prescribed in paragraph (3) of this subdivision\nand the order and protocol meet the requirements set forth in paragraph (5) of\nthis subdivision; and\n(ii)\nwith\nrespect to non-patient specific orders: (a) the immunization is prescribed or ordered by a New York State licensed and\nregistered physician or certified nurse practitioner, with a practice site in\n\nNew York State; and\n(b) if the\ncommissioner of health determines that there is an outbreak of disease, or that\nthere is the imminent threat of an outbreak of disease, then the commissioner\nof health may issue a non-patient specific regimen applicable\nstatewide. (2)\n\nAuthorized immunization agents. A\ncertified pharmacist who meets the requirements of this section shall be\nauthorized to: (i) administer to patients 18\nyears of age or older, immunizing agents to prevent influenza, pneumococcal, acute herpes zoster, hepatitis A, hepatitis B, human papillomavirus, measles, mumps, rubella, varicella, COVID-19, meningococcal, tetanus, diphtheria, or\npertussis disease, pursuant to a patient specific order or a non-patient\nspecific order; (ii)\nadminister to\npatients between the ages of two and 18 years of age, immunizing agents to\nprevent influenza, pursuant to a patient specific order or a non-patient\nspecific order; and\n(iii)\nadminister other immunizations recommended by the advisory committee on\nimmunization practices of the centers for disease control and prevention for\npatients 18 years of age or older, pursuant to a patient specific or a\nnon-patient specific order, if the commissioner of health in consultation with\nthe commissioner determines that an immunization: (a) may be safely administered by a licensed\npharmacist within their lawful scope of practice; and\n(b) is needed to prevent the transmission of\na reportable communicable disease that is prevalent in New York State; or\n(c) is a recommended\nimmunization for such patients who: (1)\nmeet\nage requirements; (2)\nlack\ndocumentation of such immunization; (3)\nlack evidence of past infection; or\n(4)\nhave an additional risk\nfactor or another indication as recommended by the advisory committee on\nimmunization practices of the centers for disease control and\nprevention. (3)\n\nRequirements for a certificate to\nadminister immunizations. No licensed pharmacist shall administer immunizing\nagents without a certificate of administration issued by the department. For\npurposes of this section, a certified pharmacist shall mean a licensed\npharmacist who is issued a certificate of administration pursuant to this\nparagraph. To meet the requirements for a certificate of administration, the\nlicensed pharmacist shall submit an application with the fee specified in\nsection\n6828\nof the\n\nEducation Law and present satisfactory evidence of completion of the\nrequirements set forth in one of the following subparagraphs: (i) Training course. Completion of a training\ncourse in the administration of immunizations acceptable to the commissioner\nand the Commissioner of Health, within the three years immediately preceding\napplication for a certificate of administration. Such course shall include, but\nnot be limited to, instruction in: (a) techniques for screening patients and for obtaining informed\nconsents; (b) techniques in the\nadministration of immunizing agents, including the injection of a harmless, non-medicinal saline solution into voluntary recipients; (c) indications, precautions and\ncontraindications in the use of immunizing agents; (d) handling of emergencies, including the\nuse of medications required for emergency treatment of anaphylaxis; (e) cardio-pulmonary resuscitation\ntechniques; and\n(f) recordkeeping\nand reporting of immunizations and information. (ii)\n\nTraining course associated with Doctor\nof Pharmacy degree: (a) graduation with a\n\nDoctor of Pharmacy degree from a professional program of study in pharmacy that\nis registered by the department pursuant to Part 52 of this Title, or is\naccredited by an acceptable accrediting agency as defined in section\n63.1\n(a) of this\n\nPart, or is determined by the department to be the equivalent of such a\nregistered or accredited program; and\n(b) completion of training in the\nadministration of immunization agents satisfactory to the department, including\ninstruction in the areas identified in subparagraph (i) of this paragraph, received as part of his/her pharmacy degree program, provided that such\ntraining was completed within the three years immediately preceding application\nfor a certificate of administration. (iii)\n\nCertificate of administration issued by\nanother jurisdiction: (a) possession of a\ncurrent certificate of administration issued by another jurisdiction, authorizing the pharmacist to administer immunization agents based on the\npharmacists completion of training or coursework in the administration of\nimmunizing agents as described in subparagraph (i) of this paragraph, or its\nequivalent as determined by the department; and\n(b) continuous practice in the administration\nof immunizing agents since the pharmacist received such training or completion\nof a retraining program in the administration of immunization agents, acceptable to the commissioner and the Commissioner of Health, provided that\nsuch retraining incorporates the areas identified in subparagraph (i) of this\nparagraph. (4)\n\nWith the exception of a certified\npharmacy intern, a certified pharmacist shall not delegate the administration\nof immunizations to an- other person. For purposes of this section, a certified\npharmacy intern shall mean a pharmacy intern who is certified to administer\nimmunization as specified in section\n6806\nof the\n\nEducation Law and has completed the requirements set forth in subdivision (d)\nof section\n63.4\nof this Part. Such a certified\npharmacy intern may only administer immunizations under the immediate personal\nsupervision of the certified pharmacist. (5)\n\nStandards, procedures and reporting\nrequirements for the administration of immunization agents. Each certified\npharmacist shall comply with the following requirements when administering an\nimmunization agent pursuant to either a patient specific order or a non-patient\nspecific order and protocol: (i) prior to\nadministering an immunization agent, a certified pharmacist shall ensure that\neach potential recipient is assessed for contraindications that would preclude\nimmunization(s); (ii)\na certified\npharmacist shall be responsible for having emergency anaphylaxis treatment\nagents, related syringes and needles available at the location at which\nimmunizations will be administered; (iii)\na certified pharmacist shall inform\neach recipient, or the person legally responsible for the recipient when the\npatient is incapable of consenting to the immunization, of potential side\neffects and adverse reactions, orally and in writing, prior to immunization and\nshall administer the immunization or immunizations according to the most\ncurrent recommendations by the advisory committee for immunization practices\n(ACIP), provided, however, that a pharmacist may administer any immunization\nauthorized when specified by a patient specific prescription; (iv)\na certified pharmacist shall not\nadminister immunizations unless the recipient is adequately informed as\nprescribed in this paragraph and the recipient consents to the immunization; except for recipients incapable of consenting to the administration of an\nimmunization, in which case, before an immunization may be administered, either\na person legally responsible for the recipient shall have given prior written\nconsent to the immunization after having been informed in writing of potential\nside effects and adverse reactions, or a person legally responsible for the\nrecipient is in attendance during the immunization and consents to the\nimmunization after having been informed of potential side effects and adverse\nreactions; (v) a certified\npharmacist shall not allow a certified pharmacy intern to administer\nimmunizations unless the recipient, or the person legally responsible for the\nrecipient when the patient is incapable of consenting to the immunization, is\ninformed that the pharmacy intern will be administering the immunization and\nthe recipient, or the person legally responsible for the recipient when the\npatient is incapable of consenting to the immunization, consents to\nadministration of the immunization by the certified pharmacy intern. If the\nrecipient, or the person legally responsible for the recipient when the patient\nis incapable of consenting to the immunization, does not consent to\nadministration by the certified pharmacy intern, then the option to receive the\nimmunization from a certified pharmacist shall be provided. (vi)\na certified pharmacist shall provide\nwritten instructions to the recipient regarding the appropriate course of\naction in the event of contraindications or adverse reactions, which statements\nare required to be developed by a competent entity knowledgeable about the\nadverse reactions of the immunization agent which shall be administered, such\nas the Centers for Disease Control of the U.S. Department of Health and Human\n\nServices, which issues vaccine information statements; (vii)\na certified pharmacist, when\nadministering an immunization in a pharmacy, shall provide for an area that\nprovides for the patient's privacy, such area shall include: (a) a clearly visible posting of the most\ncurrent \"Recommended Adult Immunization Schedule\" published by the advisory\ncommittee for immunization practices (ACIP); (b) education materials on influenza vaccines\nfor children as determined by the commissioner and the commissioner of the\ndepartment of health. (viii)\na certified pharmacist shall provide a\ncopy of the appropriate vaccine information statement to the recipient, or the\nperson legally responsible for the recipient when the patient is incapable of\nconsenting to the immunization, before administering the\nimmunization; (ix)\na certified\npharmacist shall provide to each recipient or other person legally responsible\nwhen the recipient is incapable of consenting to immunization, a signed\ncertificate of immunization with the recipient's name, date of immunization, address of administration, administering pharmacist, immunization agent, manufacturer and lot number. With the consent of the recipient or a person\nlegally responsible when the recipient is incapable of consenting, the\ncertified pharmacist shall communicate this information to the recipient's\nprimary health care practitioner, if one exists, within one month of the\nadministration of such immunization, and such communication may be transmitted\nin electronic format; (x) a\ncertified pharmacist shall report any adverse outcomes as may be required by\n\nFederal law on the vaccine adverse event reporting system form of the Centers\nfor Disease Control of the U.S. Department of Health and Human Services, or on\nthe successor form; (xi)\na\ncertified pharmacist shall ensure that a record of all persons immunized\nincluding the recipient's name, date, address of administration, administering\npharmacist, immunization agent, manufacturer and lot number is recorded and\nmaintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle; (xii)\nto the extent required\nby the Public Health Law, the Education Law and/or the New York City Health\n\nCode, a certified pharmacist shall report the administration of any\nimmunizations to the New York State Department of Health and/or the New York\n\nCity Department of Health and Mental Hygiene, in a manner required by the\n\nCommissioner of Health of the State of New York or of the City of New York, as\napplicable. Such report shall not include any individually identifiable health\ninformation unless: (a) such information is\notherwise required by law; or\n(b) the recipient has consented to the disclosure of such information, in which\ncase the information may be included to the extent permitted by law; and\n(xiii)\neach\ncertified pharmacist shall provide information to recipients on the importance\nof having a primary health care practitioner, in a form or format developed by\nthe Commissioner of Health; (xiv)\neach certified pharmacist shall, prior to administering the immunization or\nimmunizations, inform the recipient, or the person legally responsible for the\nrecipient when the patient is incapable of consenting to the immunization, of\nthe total cost of the immunization or immunizations, subtracting any health\ninsurance subsidization, if applicable. In the case where the immunization is\nnot covered, the pharmacist shall inform the recipient, or other person legally\nresponsible for the recipient when the patient is incapable of consenting to\nthe immunization, that the immunization may be covered when administered by a\nprimary care physician or health care practitioner; and\n(xv)\n\nReporting of administration of\nimmunizing agent; (a) when a licensed\npharmacist administers an immunizing agent, he or she shall report such\nadministration by electronic transmission or facsimile to the patient's\nattending primary health care practitioner or practitioners, if any, unless the\npatient is unable to communicate the identity of his or her primary health care\npractitioner, and, to the extent practicable, make himself or herself available\nto discuss the outcome of such immunization, including any adverse reactions, with the attending primary health care practitioner, or to the statewide\nimmunization registry or the citywide immunization registry, as established\npursuant to sections\n2168\nof the\n\nPublic Health Law and 11.07 of the New York City Health Code, respectively. (b) Anaphylaxis treatment agents. (1)\n\nPursuant to sections\n6801\nand\n6802\nof the\n\nEducation Law, each pharmacist who is issued a certificate of administration\npursuant to this section shall be authorized to administer medications for the\nemergency treatment of anaphylaxis to patients 2 years of age or\nolder. (2)\n\nStandards, procedures\nand reporting requirements for the administration of anaphylaxis treatment\nagents. Each certified pharmacist shall comply with the following requirements\nwhen administering medications for the emergency treatment of anaphylaxis under\nthis section: (i) each certified pharmacist\nshall ensure that a record of all persons to whom such pharmacist has\nadministered an anaphylaxis treatment agent, including but not limited to: the\nrecipient's name, date, address of administration, administering pharmacist, anaphylaxis treatment agent, manufacturer, and lot number, is recorded and\nmaintained in either a patient medication profile, if one is required, that is\nprepared and retained in conformity with section\n63.6\n(b)(7)\nof this\n\nPart; or, in the event that a patient medication profile is not required, on a\nseparate form retained by the pharmacist who administered the anaphylaxis\ntreatment agent and shall be maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle; (ii)\neach certified\npharmacist shall contact the local emergency medical services system following\nthe administration of the anaphylaxis treatment agent, or shall ensure that\nequivalent follow-up care is provided through other arrangements; and\n(iii)\ncertified pharmacists shall report to\nthe local emergency medical system or other provider of equivalent follow-up\ncare information concerning the administration of the anaphylaxis treatment\nagent, including but not limited to: the name of the agent, when it was\nadministered, the dosage, strength, and route of administration. Certified\npharmacists shall also report such information to the patient's primary health\ncare practitioner if one exists, unless the patient is unable to communicate\nthe identity of his or her primary health care practitioner. (3)\n\nNon-patient specific order and\nprotocol. (i) The certified pharmacist shall\neither maintain or ensure the maintenance of a copy of the non-patient specific\norder and protocol prescribed by a licensed physician or a certified nurse\npractitioner that authorizes such pharmacist to administer medications for the\nemergency treatment of anaphylaxis to patients 2 years of age or older, in\naccordance with the requirements of paragraph (1) of this subdivision. The\norder prescribed in subparagraph (ii) of this paragraph shall incorporate a\nprotocol that meets the requirements of subparagraph (iii) of this paragraph. Such order and protocol shall be considered a record of the patient who\nreceives the anaphylaxis treatment agent and maintained as a record for the\npatient who receives the anaphylaxis treatment agent. A record of each patient\nshall be maintained in either: (a) a patient\nmedication profile that is prepared and retained in conformity with section\n63.6\n(b)(7)\nof this\n\nPart, if one exists; or\n(b) in\ninstances where a patient medication profile does not exist, on a separate form\nthat is retained by the pharmacist who has administered the immunization, in a\nretrievable format available to the department and the patient. Such record\nshall be maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (ii)\n\nThe\nnon-patient specific order shall authorize one or more named certified\npharmacists, or certified pharmacists who are not individually named but are\nidentified as employed or under contract with an entity that is legally\nauthorized to employ or contract with pharmacists to provide pharmaceutical\nservices, to administer specified anaphylaxis treatment agents in specified\ncircumstances for a prescribed period of time. In instances in which the\ncertified pharmacists are not individually named in the order, but are\nidentified as employed or under contract with an entity that is legally\nauthorized to employ or contract with certified pharmacists to provide\npharmaceutical services, such pharmacists shall not be authorized by such order\nto administer anaphylaxis treatment agents outside of such employment or\ncontract. The order shall contain but shall not be limited to the following\ninformation: (a) the specific anaphylaxis\ntreatment agents that the certified pharmacists are permitted to\nadminister; (b) the period of time\nthat the order is effective, including the beginning and end dates; (c) the name and license number of the\ncertified pharmacist(s) authorized to administer the anaphylaxis treatment\nagent(s) pursuant to the order; or the name of the entity that is legally\nauthorized to employ or contract with certified pharmacists to provide\npharmaceutical services with whom certified pharmacists who are not\nindividually named are employed or under contract to administer the prescribed\nanaphylaxis treatment agent(s) pursuant to the order; (d) in instances in which the certified\npharmacists are not individually named in the order, but are identified as\nemployed or under contract with an entity that is legally authorized to employ\nor contract with certified pharmacists to provide pharmaceutical services, the\norder shall contain a statement limiting the certified pharmacists to\nadministering anaphylaxis treatment agents only in the course of such\nemployment or pursuant to such contract; and\n(e) the name, license number, and signature\nof the licensed physician or certified nurse practitioner who has issued the\norder. (iii)\n\nThe\nprotocol, incorporated into the order prescribed in subparagraph (ii) of this\nparagraph, shall include, but need not be limited to, the requirements set\nforth in paragraph (2) of this subdivision. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 8\nยง\n63.9\n\nAmended\n\nNew\n\nYork State Register December 30, 2015/Volume XXXVII, Issue 52, eff. 12/30/2015\n\nAmended\n\nNew\n\nYork State Register December 26, 2018/Volume XL, Issue 52, eff. 12/26/2018\n\nAmended\n\nNew\n\nYork State Register May 22, 2019/Volume XLI, Issue 21, eff. 5/22/2019\n\nAmended\n\nNew\n\nYork State Register November 3, 2021/Volume XLIII, Issue 44, eff. 11/3/2021\n\nAmended\n\nNew\n\nYork State Register June 1, 2022/Volume XLIV, Issue 22, eff. 6/1/2022\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 36050
}